References
- MitchellJAAkarasereenontPThiemermannCFlowerRJVaneJRSelectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenaseProc Natl Acad Sci U S A1993902411693116978265610
- ChamBERoss-LeeLBochnerFImhoffDMMeasurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assayTher Drug Monit1980243653727222191
- SmithWLMolecular mechanisms of aspirin actionDrug News Perspect19914362366
- ProsdocimiMFinessoMGorioACoronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dogAm J Physiol19852484 Pt 2H493H4993838623
- CerlettiCGambinoMCGarattiniSde GaetanoGBiochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vesselsJ Clin Invest19867813233263088044
- FitzGeraldGALupinettiMCharmanSACharmanWNPresystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2J Pharmacol Exp Ther19912593104310491762060
- MuirNNicholsJDCliffordJMStillingsMRHoareRCThe influence of dosage form on aspirin kinetics: implications for acute cardiovascular useCurr Med Res Opin199713105475539327189
- RowlandMRielgelmaSPharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in manJ Pharm Sci196857813131319
- BroomeTABrownMPGronwallRRCaseyMFMerittKAPharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horsesCan J Vet Res200367429730214620867
- FitzGeraldGAPedersenAKPatronoCAnalysis of prostacyclin and thromboxane biosynthesis in cardiovascular diseaseCirculation1983676117411776342834
- AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineCirculation2007116e148e30417679616
- GerrardJMMeasurements of 6-keto-prostaglandin F1 alpha and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders?Can J Physiol Pharmacol19896789229282688855
- ZimmermannNWenkAKimUFunctional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgeryCirculation2003108554254712874188
- European Medicines AgencyICH Topic E9. Statistical principles for clinical trials Available from: http://www.ema.europa.eu/pdfs/human/ich/036396en.pdfAccessed June 6, 2011
- VaneJRBakhleYSBottingRMCyclooxygenases 1 and 2Annu Rev Pharmacol Toxicol199838971209597150
- ChengYAustinSCRoccaBRole of prostacyclin in the cardiovascular response to thromboxane A2Science2002296556753954111964481
- CerlettiCGambinoMCBucchiFRajtarGRivaEde GoetanoGComparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in manAgents Actions Suppl1986202392483101444
- HammCWBassandJ-PAgewallSESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEur Heart J201132232999305421873419
- ItoSOkaRTsuchidaAYoshiokaHDisposition of single-dose intravenous and oral aspirin in childrenDev Pharmacol Ther1991173–41801861841835
- PatronoCGarcía RodríguezLALandolfiRBaigentCLow-dose aspirin for the prevention of atherothrombosisN Engl J Med2005353222373238316319386
- PatrignaniPFilabozziPPatronoCSelective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjectsJ Clin Invest1982696136613727045161
- FitzGeraldGAOatesJAHawigerJEndogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in manJ Clin Invest19837136766886338043
- DillingerJGDrissaASiderisGBiological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery diseaseAm Heart J2012164460060623067920
- RoccaBSantilliFPitoccoDThe recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetesJ Thromb Haemost20121071220123022471290
- PascaleSPetrucciGDraganiAAspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewel of the drug targetBlood2012119153595360322234683
- VejarMHackettDBrunelliCComparison of low-dose aspirin and coronary vasodilators in acute unstable anginaCirculation199081Suppl II4I112403867